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Luxury accommodations: the expanding role of structural
plasticity in protein–protein interactions
Eric J Sundberg and Roy A Mariuzza*
The recognition of multiple ligands at a single molecular
surface is essential to many biological processes.
Conformational flexibility has emerged as a compelling
strategy for association at such convergent binding sites.
Studies over the past few years have brought about a
greater understanding of the role that protein plasticity
might play in protein–protein interactions.
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There are now many known examples of proteins that
have the ability to associate with multiple ligands using
essentially the same set of surface residues. Although we
are just beginning to understand the properties that
make these consensus binding sites unique, the role of
conformational changes induced upon binding at the
protein interface has emerged as a factor of key impor-
tance. Recent structural studies have shown that plastic-
ity has at least two fundamental roles in protein–protein
interactions. First, it enables protein interfaces to accom-
modate mutations as they co-evolve. Second, it allows a
single molecular surface to interact with numerous,
structurally distinct binding partners.
Associations between proteins are essential to the regula-
tion of most cellular processes. Although the properties
that govern these interactions are not understood fully,
the rapidly expanding database of protein complex struc-
tures has revealed some factors that appear to be gener-
ally important for binding [1–3]. Most protein complexes
share a relatively large and planar buried surface area
composed of closely packed atoms, similar to those found
in the protein core. This shape complementarity is
usually accompanied by a high degree of charge comple-
mentarity, although water-mediated polar interactions
are often substituted for direct hydrogen bonds. Recent
studies [1,4,5] show that the hydrophobic effect, widely
accepted as the driving force for protein folding [6], also
has a significant role in protein–protein associations,
even though the hydrophobic nature of residues at inter-
action surfaces is intermediately dispersed between
those in the protein core and those at non-interacting
surfaces. Small, but significant conformational changes
are generally seen between non-associated and associ-
ated proteins and this flexibility appears to increase with
the amount of buried surface area in the protein complex
[2]. Although it is clear that proteins capable of binding
multiple ligands at a single site share many of the mol-
ecular properties seen in other protein–protein interac-
tions, they appear to follow a very different set of rules
when it comes to conformational flexibility.
The Fc fragment of immunoglobulin G binds to perhaps
one of the most diverse repertoires of ligands discovered
to date, including protein A [7], protein G [8], rheumatoid
factor [9] and the neonatal Fc receptor [10]. Remarkably,
all four proteins bind to a common site located between
the CH2 and CH3 domains of the Fc fragment. To deter-
mine whether this common site was selected on the basis
of biological function or because of its intrinsic binding
properties, Wells and colleagues [11] used phage display
to isolate peptides that bound the Fc fragment, without
any selection for biological function. The technique of
phage display has revolutionized the study of macromole-
cular interactions by reducing the timescale of the co-evo-
lution of protein interfaces to an experimental level.
Surprisingly, following several rounds of selection, the
library became dominated by a single peptide that
appeared to bind to the Fc consensus site with high affin-
ity. By determining the X-ray crystal structure of this 13-
residue peptide in complex with the Fc fragment the
authors found that the peptide, which is structurally unre-
lated to any of the physiological Fc ligands, buries nearly
as much surface area (650 Å2) as does the 15-fold larger
rheumatoid factor (740 Å2) and binds only twofold weaker
than does protein A. In an effort to determine distinguish-
ing features of this highly convergent binding site, Wells
and colleagues [11] carried out patch analysis over the
entire surface of the CH2 and CH3 domains of the Fc frag-
ment from five available Fc complex crystal structures.
From this analysis it was clear that the highly favorable
consensus binding site was part of a larger region of highly
accessible and hydrophobic potential binding surfaces that
extend across the top of the CH2 and CH3 domains. To
explain why the consensus site is so favorable towards
binding diverse ligands, the authors propose that greater
conformational flexibility might distinguish this site from
other similarly exposed, nonpolar sites on the Fc. Indeed,
there are significant and distinct structural rearrangements
in this region induced by each of the Fc-binding partners
(Figure 1). Much of this conformational change is medi-
ated by two neighboring methionine residues that
rearrange either to form a pocket to accommodate surface
residues of the peptide and protein G or to form a much
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flatter surface for rheumatoid factor and protein A binding.
Several other sidechains in the consensus binding site
adopt different rotamer positions to facilitate the binding
of the distinct ligands. It is likely that further plasticity of
the binding site is conferred by its position on the hinge
region of Fc between the CH2 and CH3 domains.
The inherent flexibility of such hinge domains of many
receptor families is a major factor in conferring greater
adaptability to binding surfaces. The family of cytokines
and their receptors [12] provide several examples of the
fundamental role that structural plasticity plays in cellular
signaling by enabling the accommodation of mutations
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Figure 1
Molecular surfaces of the Fc fragment at the
consensus interface region when bound by
(a) protein A, (b) protein G (c) rheumatoid
factor and (d) Fe-III, the peptide produced by
phage display that binds specifically to the 
Fc fragment consensus binding site. The
molecular footprint of each ligand, as
determined using CNS [40] with a probe
radius of 1.4 Å, is depicted in color: buried
carbon atoms are yellow, oxygen atoms red,
nitrogen atoms blue and sulfur atoms green.
The non-interacting surface residues are
uncolored. Side-by-side representations of the
differentially liganded Fc fragment molecules
are shown rotated 90° about the horizontal
axis of the figure. The ligands have been
removed for clarity. This figure was prepared
using the program GRASP [41].
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and the binding of many structurally distinct ligands. A
single molecule of human growth hormone (hGH) binds
to two hGH receptors to activate signaling [13], and the
crystal structure of the complex revealed that the asym-
metrical hGH binds to essentially the same residues on
each of the two receptors, even though there is no struc-
tural similarity between the two binding surfaces of the
growth hormone [14]. The interface between hGH and its
high-affinity receptor site has been drastically remodeled
by selecting a hGH pentamutant by phage display for
binding to its high-affinity receptor site [15]. The crystal
structure of the complex between the resulting pentamu-
tant hGH and a low-affinity mutant hGH receptor
revealed that the five hGH mutations central to the inter-
face were able to rescue binding in the complex by induc-
ing significant global conformational changes: mainchain
and sidechain atoms 15 Å from the center of the binding
interface were observed to move by up to 3 Å relative to
neighboring residues in the wild-type structure. 
Crystal structures of the erythropoietin (EPO) binding
protein (EBP) in its native unliganded form [16], bound to
EPO [17], to an agonist peptide [18], and to an antagonist
peptide [19] have revealed that dimerization of EPO
receptor molecules on the cell surface is a necessary but
insufficient event to activate this hormone receptor
system. In binding to the same site on the EPO receptor,
which itself dimerizes in unliganded form, these struc-
turally distinct agonist and antagonist molecules regulate
the activation mechanism of the receptor by orienting the
two receptor molecules in various positions relative to one
another (Figure 2). The resulting juxtaposition of the
cytosolic JAK-2 domains of the receptor, in turn, controls
their self-phosphorylation activation mechanism.
Yet another example of structural plasticity in the
cytokine family was revealed by the crystal structure of a
complex between interferon-γ and its high-affinity recep-
tor [20]. A flexible loop in the unbound form of interferon-
γ undergoes radical conformational changes upon receptor
binding, including the formation of a 310 helix.
Because of the inherently greater morphological diversity of
foreign antigens relative to the immune system recognition
molecules, antibodies and T-cell receptors (TCRs), the
structural flexibility of the recognition domains in these
molecules has been proposed to be an essential component
of immune recognition. The structures of these molecules
seem to present ideal scaffolds for antigen-recognition-
based structural plasticity owing to the conformational
arrangement of six complementarity determining region
(CDR) loops extending from the variable light (VL) and
heavy (VH) chains of antibodies, and from the variable α andβ domains of the TCR (Vα and Vβ). Indeed, a wide range of
conformational changes induced upon ligand binding have
been reported for both of these classes of molecules.
Several examples of an ‘induced-fit’ mechanism have
been described for antibody recognition of small mol-
ecules, including peptides [21,22] and nucleotides [23],
whereby substantial rearrangements of the CDR loops and
relative rotations of the VL and VH domains were
observed. Interestingly, large rearrangements of CDR
loops have not been observed in antibody complexes with
protein antigens [24,25]. Thus, the induced-fit mechanism
of antigen binding may be pertinent only to small-mol-
ecule–antibody interactions, such as for peptides,
nucleotides and haptens, necessitated by excessive
antigen envelopment. A possible role of structural plastic-
ity in antibody maturation was revealed by the crystal
structures of a germline antibody in both its hapten-bound
and free forms [26], in which the substantial conforma-
tional changes incurred upon complex formation were
structurally similar to the mature antibody.
Functional TCR molecules must have dual specificity. In
the thymus, T cells are selected for maturation on the basis
of weak interactions between the TCR and self-peptides
presented by major histocompatibility complex molecules
(pMHC). Surviving T cells then survey pMHC complexes
on cellular surfaces in the periphery. Encounters with self
and foreign pMHC complexes can lead to a wide range of
agonist and antagonist T-cell signaling mechanisms, depen-
dent on the affinity of the pMHC–TCR interaction [27].
Plasticity in the CDR loops of TCR molecules provides one
explanation as to how T cells can perform their immunoreg-
ulatory duties by recognizing different molecular surfaces
from those on which they were originally selected. The
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Figure 2
Relative juxtapositions of the erythropoietin (EPO) binding protein (EBP)
dimer pairs when bound by the natural agonist EPO (green), a weak
peptide agonist EMP1 (blue) and an antagonist peptide EMP33 (red).
Domain 1 (D1) β-strand residues of one EBP molecule of each complex
were superimposed by least-squares fitting in XTALVIEW [42]. The D1
domains of the second EBP molecule of each EBP dimer pair, when
bound by EMP1 and EMP33 are situated approximately 15° and 60°,
respectively, away from the axis along the two EBP D1 domains of the
EPO–EBP complex. The ligands have been removed for clarity. This
figure was prepared using the program MOLSCRIPT [43].
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structure of a complex between self pMHC and its specific
TCR [28] has provided some insights into the role of struc-
tural plasticity in the development and activation of T cells.
Notably, there is very poor shape complimentarity at the
pMHC–TCR interface. By comparison to structures of the
individual unliganded molecules, numerous conformational
changes induced upon binding pMHC were observed in
the CDR loops of the TCR, similar to the antibody
rearrangements induced by small molecules. The largest of
these conformational changes occurs in the CDR3 loop of
the TCR α chain in which a type II′ β turn in the unli-
ganded structure undergoes a movement of 6 Å in order to
accommodate the pMHC α2 helix. These types of confor-
mational changes induced by pMHC in the CDR loops of
TCRs might be important for differentiating between
superagonist and weak agonist signaling [29]. Recent ther-
modynamic analyses of pMHC–TCR complexes [30,31]
have indicated that these interactions are highly tempera-
ture dependent, characteristic of induced fit mechanisms,
and implicate TCR flexibility as an essential component of
specific binding to pMHC ligands.
Recently developed nuclear magnetic resonance (NMR)
techniques are able to distinguish intramolecular motions
over a wide range of timescales on a per residue basis
[32,33]. A number of studies that take advantage of these
techniques have revealed significant overlap in residues that
have a high degree of structural flexibility and those that are
important in protein–protein interactions; this is especially
true for residues that bind multiple ligands  [34,35].
Despite the finding of common binding sites on many
biologically important molecules, it would be incorrect to
believe that proteins, in general, are competent to bind
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Figure 3
Major histocompatibility class I molecules bind
numerous ligands at distinct binding surfaces,
including (a) the T-cell receptor (TCR), (b) the
CD8αα homodimer, (c) the lectin-like natural
killer (NK) cell receptor Ly49A, and (d) the NK
inhibitory receptor KIR2DL2. The MHC heavy
chain and β-2-microglobulin are shown in
blue, the antigenic peptide is in red, and the
ligands TCR, CD8αα, Ly49A and KIR2DL2
are in green. This figure was prepared using
the program MOLSCRIPT [43]. 
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ligands at only very restricted locations on their surface.
Several striking counter-examples to this binding strategy
exist, including MHC class I molecules, which interact
with TCRs, natural killer (NK) cell receptors, and the
accessory molecule CD8. As shown in Figure 3, these
MHC class I ligands all bind to very distinct surfaces of
the pMHC complex. TCR molecules bind across the top
of the MHC α helices and interact with the antigenic
peptide [28]. The accessory molecule CD8 binds as a
CD8αα homodimer to a surface comprised of residues
from the HLA-A2 α2 and α3 domains (HLA, human
leukocyte antigen) as well as residues from β-2-microglob-
ulin [36]. Two recently solved complexes of MHC class I
molecules bound by NK cell receptors also revealed very
different modes of interaction. The lectin-like NK cell
receptor Ly49A binds to two sites on the MHC molecule
H-2Dd [37], one which partially overlaps the CD8-
binding site and another at a conserved glycosylation site
of the α2 domain of the MHC molecule. The NK
inhibitory receptor KIR2DL2 binds in a peptide-depen-
dent manner along the top of the HLA-Cw3 molecule dis-
playing an importin α2 peptide [38]. In contrast to the
consensus site on the Fc fragment, each of these MHC
class I binding surfaces is relatively hydrophilic. Particu-
larly in the Ly49A (both interaction sites) and KIR2DL2
complexes, the interfaces are dominated by polar interac-
tions, including numerous salt bridges. Another counter-
example to the scenario of a single receptor surface
binding multiple ligands is seen in the case of hen egg
white lysozyme. Crystal structures of hen egg white
lysozyme in complex with a number of antilysozyme mon-
oclonal antibodies have revealed that numerous distinct
molecular surfaces can function as epitopes [39].
Thus, although one must exercise considerable caution in
making generalizations about the structural characteristics
of ligand-binding sites on proteins, the need for expanding
the database of protein structures in both their complexed
and uncomplexed forms is evident. This information,
coupled with techniques for co-evolving protein surfaces
and more specifically defining the energetically important
residues in the binding interface and their individual
atomic movements, will provide a much clearer under-
standing of the importance of structural plasticity in
protein–protein interactions in the near future.
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